Mark T. Wagner

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2010 · 652 citations · Full text

Psychotherapy, Psychotropic Medication, Psychopharmacology +21

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia et al. · The Lancet Psychiatry · 2018 · 426 citations

Psychiatric Evaluation, Psychiatry, Adult Behavioral Health +12

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Michael C. Mithoefer, Mark T. Wagner, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2012 · 367 citations · Full text

RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome et al. · Psychopharmacology · 2019 · 357 citations · Full text

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Mark T. Wagner, Michael C. Mithoefer, Ann T. Mithoefer et al. · Journal of Psychopharmacology · 2017 · 156 citations · Full text